Page 11 - Forefront Analytics News Today

Cantor Fitzgerald reissued their overweight rating on shares of ALX Oncology (NASDAQ:ALXO – Free Report) in a research note published on Monday morning, Benzinga reports. Cantor Fitzgerald currently has a $22.00 price objective on the stock. Separately, Lifesci Capital restated an outperform rating on shares of ALX Oncology in a research report on Wednesday, April […]

Orchard Therapeutics plc (NASDAQ:ORTX – Get Free Report) shares were up 0.4% during mid-day trading on Tuesday . The company traded as high as $5.20 and last traded at $5.11. Approximately 13,587 shares changed hands during trading, a decline of 83% from the average daily volume of 78,334 shares. The stock had previously closed at […]

Invesco DWA Momentum ETF (NASDAQ:PDP – Get Free Report) reached a new 52-week high on Wednesday . The company traded as high as $81.73 and last traded at $81.56, with a volume of 1107 shares trading hands. The stock had previously closed at $81.04. Invesco DWA Momentum ETF Stock Up 0.7 % The firm has […]

Invesco DWA Momentum ETF (NASDAQ:PDP – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $81.73 and last traded at $81.56, with a volume of 1107 shares traded. The stock had previously closed at $81.04. Invesco DWA Momentum ETF Stock Up 0.7 […]

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Free Report) CEO Jaume Pons sold 3,208 shares of the company’s stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $7.34, for a total value of $23,546.72. Following the completion of the sale, the chief executive officer now owns 536,538 shares […]

Nkarta, Inc. (NASDAQ:NKTX – Free Report) – Stock analysts at William Blair reduced their Q2 2024 earnings per share (EPS) estimates for shares of Nkarta in a report issued on Tuesday, June 27th. William Blair analyst S. Corwin now forecasts that the company will post earnings per share of ($0.80) for the quarter, down from […]

CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has been assigned an average recommendation of “Hold” from the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have given a buy recommendation to the company. […]

Pathstone Family Office LLC increased its holdings in shares of iShares Gold Trust (NYSEARCA:IAU – Get Rating) by 12.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,231 shares of the exchange traded fund’s stock after buying an additional […]

Tang Capital Management LLC acquired a new stake in Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 485,234 shares of the company’s stock, valued at approximately $1,538,000. A number of other institutional investors also recently bought and […]

Forefront Analytics LLC decreased its position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) by 48.2% in the 4th quarter, HoldingsChannel reports. The fund owned 24,787 shares of the biotechnology company’s stock after selling 23,082 shares during the period. Forefront Analytics LLC’s holdings in CytomX Therapeutics were worth $40,000 as of its most […]